CBL-514 injectable lipolysis treatment is intended to reduce subcutaneous fat. Credit: CHAjAMP/Shutterstock. Taiwanese biopharmaceutical company Caliway Biopharmaceuticals announced that a Phase II trial of its injectable…
CBL-514 is the first product to treat cellulite in raised areas. Currently, there is no effective and safe treatment for cellulite on the market. The global…
TAIPEI, September 18, 2023 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway), a biopharmaceutical company focused on innovative medical aesthetics and inflammatory medicine discovery of small molecule therapeutics, announced…
